IL181896A0
(en )
2007-07-04
Methods and compositions for the treatment of hyperlipidemia
GB0522311D0
(en )
2005-12-07
Pharmaceutical compositions for the treatment of pain
IL208607A0
(en )
2010-12-30
Improved nanobodiestm for the treatment of aggregation-mediated disorders
PL1765391T3
(en )
2013-08-30
Bacterial compositions for the treatment of cancer
EP1863899A4
(en )
2009-12-30
Skin treatment compositions
ZA200703087B
(en )
2009-04-29
Methods and compositions for the treatment of hyperlipidemia
IL187405A0
(en )
2011-07-31
Methods and compositions for the treatment of pain
ZA200708033B
(en )
2008-11-26
Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia
HK1111599A1
(en )
2008-08-15
Pharmaceutical compositions for the treatment of cellulite
HK1097831A1
(en )
2007-07-06
Benzopyran compounds useful for the treatment of arrhytmia
EP1904088A4
(en )
2010-03-31
Compositions and methods for the treatment of cancer
HU0500145D0
(en )
2005-04-28
Composition for the treatment of oral diseases
EP1755581A4
(en )
2008-01-02
Methods and compositions for the treatment of myocardial conditions
EP1865952A4
(en )
2009-11-04
Histamine-containing composition for the treatment of allergic diseases
HUP0500947A2
(en )
2007-08-28
Composition for treatment of paradontosis
ZA200710476B
(en )
2009-10-28
Methods and compositions for the treatment of pain
ZA200606780B
(en )
2008-08-27
Compounds for the treatment of diseases
GB0313630D0
(en )
2003-07-16
Compositions for the enhanced treatment of depression
GB0505203D0
(en )
2005-04-20
Skin composition treatment
ZA200410080B
(en )
2007-03-28
Composition for the treatment of humans
HUP0500948A2
(en )
2007-08-28
Composition for treatment of diabeticus paradontosis
GB0602857D0
(en )
2006-03-22
The treatment of sialorrhoea
GB2441581B
(en )
2011-01-19
Compositions and methods for the treatment of muscle wasting
TJ20050863A
(en )
2007-06-05
The way of narcotism treatment
GB0423927D0
(en )
2004-12-01
The treatment of IBD